You are here

Drug Safety Revisions: FDA Update

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
The author reviews new warnings and label changes for sirolimus (Rapamune®), pergolide mesylate (Permax®), and salmeterol xinafoate inhalation aerosol (Serevent®).